Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Dermatology

  • News

    Biologics may protect psoriasis patients against severe COVID-19

    November 2, 2020

    Preliminary evidence suggests biologics prevent the fearsome COVID-19 late cytokine storm.

  • News

    COVID-19 outcomes no worse in patients on TNF inhibitors or methotrexate

    September 16, 2020

    No increase was seen in hospitalization and death rates, providing additional support for keeping patients on these immunosuppressive treatments during the COVID-19 pandemic, although more research is needed and shared decision making is warranted.

  • News

    Cutaneous clues linked to COVID-19 coagulation risk

    August 6, 2020

    These skin signs could augment coagulation assays in this patient population.

  • Opinion

    COVID-19–related skin changes: The hidden racism in documentation

    July 31, 2020

    It is not a stretch to suggest that skin manifestations associated with COVID-19 may look very different in darker skin.

  • 1
    News

    More data needed to better understand COVID-19 skin manifestations

    July 31, 2020

    Histopathologic exams were done for only 23 patients and, in all cases, showed “inflammatory features without specific pathological changes.”

  • 1
    News

    Is the presence of enanthem a clue for COVID-19?

    July 24, 2020

    In the study, six of the patients presented with oral lesions, all of them located in the palate.

  • 1
    News

    Even a few days of steroids may be risky, new study suggests

    July 9, 2020

    A retrospective study of more than 2.6 million Taiwanese adults echoes findings from a 2017 cohort study of more than 1.5 million U.S. adults.

  • 1
    News

    Lifestyle changes may explain skin lesions in pandemic-era patients

    July 2, 2020

    "Dermatologists must be aware of the protean cutaneous findings that are possibly associated with COVID-19, even if our understanding of their origins remains incomplete."

  • 1
    News

    Skin patterns of COVID-19 vary widely

    June 29, 2020

    “There’s a lot that we still don’t know, and some patterns are going to be outliers,” Dr. Christine Ko said.

  • News

    COVID-19 complicates prescribing for children with inflammatory skin disease

    May 27, 2020

    Pediatric dermatologists say they would continue children on most immunosuppressive treatments, but are more reluctant to initiate.

Previous1 2 3 4 5Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences